Physician profile
Mark P Abrams
NPI 1063755213
$30,390.27
in general payments reported to CMS, 2019-2025
11 companies · $282 in 2025
The $282 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,360 · 2020: $16K · 2021: $6,640 · 2022: $190 · 2023: $67.74 · 2024: $142 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $491.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $13,200.39 | 2019-2020 | |
| Boston Scientific Corporation | $9,345.51 | 2019-2025 | General - Therapies, Watchdog |
| Abbott Laboratories | $6,306.14 | 2019-2024 | Aveir |
| Medtronic, INC. | $873.82 | 2021-2025 | Affera Mapping System |
| Biosense Webster, INC. | $386.64 | 2021 | |
| Philips North America LLC | $137.78 | 2021 | |
| Irhythm Technologies, INC. | $67.74 | 2023 | Zio Xt Patch |
| Astellas Pharma US INC | $23.77 | 2019 | |
| Cardiva Medical, INC. | $19.35 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $16.84 | 2019 | |
| Baxter Healthcare | $12.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Abrams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.